# PERICLES (NCT03686332)

> PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03686332
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: The Netherlands Cancer Institute
- Conditions: Penile Cancer
- Interventions: Arm A: Atezolizumab and Radiotherapy; Arm B: Atezolizumab
- Enrollment: 32
- Primary outcome: Progression-free survival at 1 year.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 7
- YouTube: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=pericles-nct03686332

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03686332", "email": "<work email>"}; the inbox owner confirms by the emailed link.